The invention relates to processes for manufacturing a compound of formula (5) or a stereoisomer, tautomer or a salt thereof, wherein the substituents are as defined in the specification. The invention further relates to new manufacturing processes for specific solid forms of Compound A and its salts, to such solid forms and to use of said solid forms for the therapeutic treatment of warm-blooded animals.
申请公布号
CA2813333(A1)
申请公布日期
2012.04.05
申请号
CA20112813333
申请日期
2011.09.29
申请人
NOVARTIS AG
发明人
CALIENNI, JOHN VINCENT;DE LA CRUZ, MARILYN;FLUBACHER, DIETMAR;GONG, BAOQING;KAPA, PRASAD KOTESWARA;KARPINSKI, PIOTR H.;LIU, HUI;MICHEL, PASCAL;MOSE, RASMUS;TESTA, MARIA CATERINA;WAYKOLE, LILADHAR MURLIDHAR